PRISCIANDARO, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 899
EU - Europa 535
AS - Asia 317
OC - Oceania 15
AF - Africa 8
SA - Sud America 8
Totale 1.782
Nazione #
US - Stati Uniti d'America 879
IT - Italia 241
CN - Cina 190
GB - Regno Unito 54
IE - Irlanda 54
DE - Germania 41
IN - India 39
FR - Francia 35
JP - Giappone 27
NL - Olanda 20
CA - Canada 19
HK - Hong Kong 19
AU - Australia 13
RO - Romania 11
CZ - Repubblica Ceca 10
FI - Finlandia 10
UA - Ucraina 10
ES - Italia 9
NO - Norvegia 8
RU - Federazione Russa 8
TR - Turchia 8
DK - Danimarca 7
VN - Vietnam 7
KR - Corea 5
SE - Svezia 5
CL - Cile 4
PK - Pakistan 4
SY - Repubblica araba siriana 4
CO - Colombia 3
EG - Egitto 3
PL - Polonia 3
SG - Singapore 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
GR - Grecia 2
IR - Iran 2
PT - Portogallo 2
TW - Taiwan 2
UG - Uganda 2
ZA - Sudafrica 2
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BR - Brasile 1
CH - Svizzera 1
CY - Cipro 1
ID - Indonesia 1
IQ - Iraq 1
JO - Giordania 1
MA - Marocco 1
MX - Messico 1
MY - Malesia 1
NZ - Nuova Zelanda 1
VU - Vanuatu 1
Totale 1.782
Città #
Fairfield 85
Milan 82
Houston 74
Ashburn 66
Dublin 54
Woodbridge 54
Beijing 47
Santa Cruz 46
Buffalo 45
Seattle 40
Ann Arbor 35
Shanghai 32
Wilmington 27
Southend 20
Cambridge 19
Chicago 14
Boardman 13
Las Vegas 13
Bengaluru 9
Nanjing 9
Chengdu 8
Helsinki 8
Toronto 8
Bucharest 7
Central District 7
Columbus 7
Los Angeles 7
Oslo 7
Rome 7
Dallas 6
London 6
New York 6
Ottawa 6
Aarhus 5
Atlanta 5
Elmont 5
Fuzhou 5
Hyderabad 5
Padova 5
Phoenix 5
Wuhan 5
Amsterdam 4
Berlin 4
Bogen 4
Falls Church 4
Florence 4
Futabacho 4
Jinan 4
Rostov-on-don 4
Rotterdam 4
San Diego 4
Tokyo 4
Turin 4
Changchun 3
Citta 3
Clearwater 3
Des Moines 3
Duncan 3
Guangzhou 3
Hangzhou 3
Ho Chi Minh City 3
Kwai Chung 3
Lake Forest 3
Mumbai 3
Newcastle 3
Norwalk 3
Paris 3
Philadelphia 3
Pune 3
Rho 3
Seoul 3
Sunnyvale 3
Taizhou 3
Verona 3
West Wickham 3
Ancona 2
Assago 2
Baotou 2
Bartlesville 2
Belsize Park 2
Bergamo 2
Boston 2
Caserta 2
Cedar Knolls 2
Changsha 2
Copenhagen 2
Council Bluffs 2
Delhi 2
Dresden 2
Genoa 2
Giza 2
Glen Iris 2
Gölcük 2
Habikino 2
Heidelberg 2
Islamabad 2
Kocaeli 2
Kowloon 2
Kyoto 2
Lublin 2
Totale 1.078
Nome #
Optimized EGFR blockade strategies in EGFR addicted gastroesophageal adenocarcinomas, file dfa8b9a5-fa3e-748b-e053-3a05fe0a3a96 468
Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?, file dfa8b99a-5c11-748b-e053-3a05fe0a3a96 184
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease Burden, file dfa8b9a3-69fe-748b-e053-3a05fe0a3a96 169
The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict efficacy of platinum-based chemotherapy in patients with metastatic triple negative breast cancer, file dfa8b99d-4684-748b-e053-3a05fe0a3a96 160
Vinorelbine in BRAF V600E mutated metastatic colorectal cancer: a prospective multicentre phase II clinical study, file dfa8b99a-a547-748b-e053-3a05fe0a3a96 124
The added value of baseline circulating tumor DNA profiling in patients with molecularly hyperselected, left-sided metastatic colorectal cancer, file dfa8b9a8-2a19-748b-e053-3a05fe0a3a96 123
Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak : COVID-19-adapted Recommendations of the National Cancer Institute of Milan, file dfa8b9a3-2313-748b-e053-3a05fe0a3a96 107
Clinical Behavior and Treatment Response of Epstein-Barr Virus–Positive Metastatic Gastric Cancer : Implications for the Development of Future Trials, file dfa8b9a3-31ad-748b-e053-3a05fe0a3a96 101
The landscape of actionable gene fusions in colorectal cancer, file dfa8b9a0-7c6f-748b-e053-3a05fe0a3a96 88
Prognostic impact of early tumor shrinkage and depth of response in patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors, file dfa8b9a6-d5d1-748b-e053-3a05fe0a3a96 81
Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: The CARACAS study, file dfa8b9a9-6feb-748b-e053-3a05fe0a3a96 59
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers, file ad5d0e0e-96e9-4c72-adc5-6ee59820e0de 55
Tremelimumab and durvalumab combination for the non-operative management (NOM) of microsatellite instability (MSI)-high resectable gastric or gastroesophageal junction cancer : The multicentre, single-arm, multi-cohort, phase II INFINITY study, file dfa8b9a8-441d-748b-e053-3a05fe0a3a96 40
Impact of early tumor shrinkage and depth of response on the outcomes of panitumumab-based maintenance in patients with RAS wild-type metastatic colorectal cancer, file dfa8b9a9-d5a6-748b-e053-3a05fe0a3a96 32
Reinduction of an Anti-EGFR-based First-line Regimen in Patients with RAS Wild-type Metastatic Colorectal Cancer Enrolled in the Valentino Study, file 69aef1ba-f2a6-41fd-8cb5-f86e7d8c19f0 17
Biomarkers of Primary Resistance to Trastuzumab in HER2-Positive Metastatic Gastric Cancer Patients : the AMNESIA Case-Control Study, file dfa8b99a-6e8a-748b-e053-3a05fe0a3a96 5
TREMELIMUMAB AND DURVALUMAB COMBINATION FOR THE NON-OPERATIVE MANAGEMENT OF MICROSATELLITE INSTABILITY HIGH RESECTABLE GASTRIC OR GASTROESOPHAGEAL JUNCTION CANCER: RESULTS OF COHORT 1 OF THE MULTICENTRE, SINGLE-ARM, MULTI-COHORT, PHASE II INFINITY STUDY, file fa60a5ee-cd19-4b1a-94b3-202a0583568d 5
Biomarkers of Primary Resistance to Trastuzumab in HER2-Positive Metastatic Gastric Cancer Patients : the AMNESIA Case-Control Study, file dfa8b99b-479f-748b-e053-3a05fe0a3a96 4
Estimating Survival Probabilities of Advanced Gastric Cancer Patients in the Second-Line Setting: The Gastric Life Nomogram, file dfa8b99c-4bbc-748b-e053-3a05fe0a3a96 4
Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer : a Retrospective Comparison of Efficacy and Safety Profiles, file dfa8b99d-4531-748b-e053-3a05fe0a3a96 4
Validation of the Colon Life nomogram in patients with refractory metastatic colorectal cancer enrolled in the RECOURSE trial, file dfa8b9a3-8aac-748b-e053-3a05fe0a3a96 4
RET fusions in a small subset of advanced colorectal cancers at risk of being neglected, file dfa8b99c-5582-748b-e053-3a05fe0a3a96 2
Pembrolizumab in the treatment of advanced/metastatic melanoma: a single-center institution experience, file dfa8b99d-056c-748b-e053-3a05fe0a3a96 2
Perioperative Bevacizumab-based Triplet Chemotherapy in Patients with Potentially Resectable Colorectal Cancer Liver Metastases, file dfa8b99d-3d1c-748b-e053-3a05fe0a3a96 2
Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives, file dfa8b99e-f2c0-748b-e053-3a05fe0a3a96 2
Retreatment With Anti-EGFR Antibodies in Metastatic Colorectal Cancer Patients : A Multi-institutional Analysis, file dfa8b9a3-6fe0-748b-e053-3a05fe0a3a96 2
Recent Advances in the Management of Typical and Atypical Lung Carcinoids, file dfa8b9a9-a8ed-748b-e053-3a05fe0a3a96 2
Systemic doxycycline for pre-emptive treatment of anti-EGFR-related skin toxicity in patients with metastatic colorectal cancer receiving first-line panitumumab-based therapy: a post hoc analysis of the Valentino study, file dfa8b9a9-b4e8-748b-e053-3a05fe0a3a96 2
Differential histopathologicparameters in colorectal cancer liver metastases resected after triplets plus bevacizumab or cetuximab: a pooled analysis of five prospective trials, file dfa8b99b-aed9-748b-e053-3a05fe0a3a96 1
Immune-related adverse events correlate with improved survival in patients undergoing anti-PD1 immunotherapy for metastatic melanoma, file dfa8b99d-ccd7-748b-e053-3a05fe0a3a96 1
Totale 1.850
Categoria #
all - tutte 5.022
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.022


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201936 0 0 0 0 0 0 0 0 0 0 19 17
2019/2020140 12 9 7 15 12 13 15 10 19 12 8 8
2020/2021323 2 17 19 16 18 27 15 27 29 40 60 53
2021/2022684 61 55 44 78 81 41 49 44 51 31 106 43
2022/2023366 10 25 81 53 29 40 30 15 16 12 37 18
2023/2024244 24 22 22 21 23 19 39 32 19 14 9 0
Totale 1.850